WASHINGTON – U. S. gets third vaccine to save him from Covid-19, while on Saturday the Food and Drug Administration legalized a Johnson vaccine
Health experts are eagerly awaiting a singles option to speed up vaccines while competing against a virus that has already killed more than 510,000 people in the United States and is mutating unsettlingly.
The FDA has that J vaccine
“This is good news,” Dr. Francis Collins, director of the National Institutes of Health, told The Associated Press on Saturday. “The most we can do now is take as many blows to the arm as possible. “
J
J
“This is exciting news for all Americans and an encouraging progression in our efforts to end the crisis,” President Joe Biden said in a statement. “But I must be clear: this fight is over,” he added, encouraging others. stick to the mask and other public fitness measures.
On Sunday, a U. S. advisory committee will be able to find a U. S. But it’s not the first time You will meet to consider how to prioritize the use of the single-dose vaccine and a big challenge is what the public should know: which is the best?
“In this environment, all that can be achieved,” said Dr. Arnold Monto of the University of Michigan, who chaired an FDA advisory organization that voted unanimously Friday that the vaccine outweighs its risks.
The data are combined on the effectiveness of all vaccines used in the world, which has led some countries to report that others refuse to wait one type to another.
In the United States, two-dose injections of Pfizer and Moderna were 95% opposed to symptomatic Covid-19.
Collins of the NIH said the evidence shows no explanation as to why to promote one vaccine over another.
“What interests me most, I think, will save you from getting sick?”Collins says. ” Will you save me from dying of this terrible disease?The good news is that all this says yes.
In addition, J
The FDA warned that it is too early to tell if a user who contracted a mild or asymptomatic infection despite vaccination may continue to spread the virus.
There are apparent benefits in addition to the convenience of one at a time. Local fitness officials should use option J
Vaccine J
“We’re running for more supply. That’s what restricts us right now,” said Dr. Matt Anderson of UW Health in Madison, Wisconsin, where they were preparing electronic fitness records, ing and vaccine stores in preparation for what will soon be providing J vaccines.
The FDA said studies did run into serious side effects. Like other Covid-19 vaccines, the main side effects of the J vaccine
An FDA data sheet for vaccinated users indicates that there is a “low probability” that other people will revel in a severe allergic reaction to the vaccine, a rare threat observed with Pfizer and Moderna vaccines. These reactions are treatable and vaccine receptors are expected to be briefly monitored after injection.
The vaccine has been approved for emergency use in adults over the age of 18 at this time, but like manufacturers, J
All Covid-19 vaccines exercise the framework to recognize the new coronavirus, detecting the pointed protein that covers it, but they are manufactured in many other ways.
j
Pfizer and Moderna vaccines are manufactured with other technology, a fragment of genetic code called messenger RNA that stimulates cells to produce those innocent copies.